3 mL

DRUG2 trials

Sponsors

Novo Nordisk A/S, Amsterdam UMC Stichting

Conditions

Non-alcoholic steatohepatitis (NASH)subarachnoid hemorrhage

Phase 2

Improving outcome in subarachnoid hemorrhage with nadroparin

Not yet recruitingCTIS2024-511679-14-00

Amsterdam UMC Stichtingsubarachnoid hemorrhage

Target: 100Updated: 2024-08-08

Phase 3

The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis

Active, not recruitingCTIS2023-506962-30-00

Novo Nordisk A/SNon-alcoholic steatohepatitis (NASH)

Start: 2021-03-29Target: 219Updated: 2025-11-11